Analysis and Commentary STEVEN GROSSMAN 11/4/17 Analysis and Commentary STEVEN GROSSMAN 11/4/17 FDA Is Its People ... and They Need Our Support Read More Advocacy at a Glance STEVEN GROSSMAN 11/4/17 Advocacy at a Glance STEVEN GROSSMAN 11/4/17 Worth A Second Look: “Not Your Father’s FDA” and more Read More Analysis and Commentary STEVEN GROSSMAN 10/27/17 Analysis and Commentary STEVEN GROSSMAN 10/27/17 Building a Truely 21st Century Regulatory Agency Read More Advocacy at a Glance STEVEN GROSSMAN 10/27/17 Advocacy at a Glance STEVEN GROSSMAN 10/27/17 FDA Wants Public Input on Improving the Agency’s Website Read More Analysis and Commentary STEVEN GROSSMAN 10/20/17 Analysis and Commentary STEVEN GROSSMAN 10/20/17 Not Your Father's FDA Read More Advocacy at a Glance STEVEN GROSSMAN 10/20/17 Advocacy at a Glance STEVEN GROSSMAN 10/20/17 Changes and Growth at the FDA Read More Analysis and Commentary STEVEN GROSSMAN 10/13/17 Analysis and Commentary STEVEN GROSSMAN 10/13/17 The FDA Deserves Special Consideration at Budget-Time Read More Advocacy at a Glance STEVEN GROSSMAN 10/13/17 Advocacy at a Glance STEVEN GROSSMAN 10/13/17 Senate Budget Vote Likely the Week of October 16 Read More Analysis and Commentary STEVEN GROSSMAN 10/6/17 Analysis and Commentary STEVEN GROSSMAN 10/6/17 FDA Stakeholders Need to Start to "Up Our Game" Read More Advocacy at a Glance STEVEN GROSSMAN 10/6/17 Advocacy at a Glance STEVEN GROSSMAN 10/6/17 House Passes FY 18 Budget Resolution; Differs from Senate Version and more Read More Analysis and Commentary STEVEN GROSSMAN 9/29/17 Analysis and Commentary STEVEN GROSSMAN 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Ever Wonder What FDA Was Like A Decade Ago and more Read More Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Where We're at Now and What's Coming Next Read More Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Next Funding Battle: Congress Must Deal with Budget Caps Read More Advocacy at a Glance STEVEN GROSSMAN 9/15/17 Advocacy at a Glance STEVEN GROSSMAN 9/15/17 Where to Stash the 18,000 Bodies: a Master Plan Read More Advocacy at a Glance STEVEN GROSSMAN 9/15/17 Advocacy at a Glance STEVEN GROSSMAN 9/15/17 House Passes FY 18 Omnibus Appropriations Bill Including Ag/FDA Funds Read More Analysis and Commentary STEVEN GROSSMAN 9/8/17 Analysis and Commentary STEVEN GROSSMAN 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More Advocacy at a Glance STEVEN GROSSMAN 9/8/17 Advocacy at a Glance STEVEN GROSSMAN 9/8/17 Senate Passes FY 18 CR Through December 8 and more Read More Advocacy at a Glance STEVEN GROSSMAN 9/1/17 Advocacy at a Glance STEVEN GROSSMAN 9/1/17 A "Breather", a Summary Review, and a Re-commitment Read More Advocacy at a Glance STEVEN GROSSMAN 9/1/17 Advocacy at a Glance STEVEN GROSSMAN 9/1/17 A Busy and Consequential Month for Congress and more Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 11/4/17 Analysis and Commentary STEVEN GROSSMAN 11/4/17 FDA Is Its People ... and They Need Our Support Read More
Advocacy at a Glance STEVEN GROSSMAN 11/4/17 Advocacy at a Glance STEVEN GROSSMAN 11/4/17 Worth A Second Look: “Not Your Father’s FDA” and more Read More
Analysis and Commentary STEVEN GROSSMAN 10/27/17 Analysis and Commentary STEVEN GROSSMAN 10/27/17 Building a Truely 21st Century Regulatory Agency Read More
Advocacy at a Glance STEVEN GROSSMAN 10/27/17 Advocacy at a Glance STEVEN GROSSMAN 10/27/17 FDA Wants Public Input on Improving the Agency’s Website Read More
Analysis and Commentary STEVEN GROSSMAN 10/20/17 Analysis and Commentary STEVEN GROSSMAN 10/20/17 Not Your Father's FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 10/20/17 Advocacy at a Glance STEVEN GROSSMAN 10/20/17 Changes and Growth at the FDA Read More
Analysis and Commentary STEVEN GROSSMAN 10/13/17 Analysis and Commentary STEVEN GROSSMAN 10/13/17 The FDA Deserves Special Consideration at Budget-Time Read More
Advocacy at a Glance STEVEN GROSSMAN 10/13/17 Advocacy at a Glance STEVEN GROSSMAN 10/13/17 Senate Budget Vote Likely the Week of October 16 Read More
Analysis and Commentary STEVEN GROSSMAN 10/6/17 Analysis and Commentary STEVEN GROSSMAN 10/6/17 FDA Stakeholders Need to Start to "Up Our Game" Read More
Advocacy at a Glance STEVEN GROSSMAN 10/6/17 Advocacy at a Glance STEVEN GROSSMAN 10/6/17 House Passes FY 18 Budget Resolution; Differs from Senate Version and more Read More
Analysis and Commentary STEVEN GROSSMAN 9/29/17 Analysis and Commentary STEVEN GROSSMAN 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More
Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Ever Wonder What FDA Was Like A Decade Ago and more Read More
Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Where We're at Now and What's Coming Next Read More
Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Next Funding Battle: Congress Must Deal with Budget Caps Read More
Advocacy at a Glance STEVEN GROSSMAN 9/15/17 Advocacy at a Glance STEVEN GROSSMAN 9/15/17 Where to Stash the 18,000 Bodies: a Master Plan Read More
Advocacy at a Glance STEVEN GROSSMAN 9/15/17 Advocacy at a Glance STEVEN GROSSMAN 9/15/17 House Passes FY 18 Omnibus Appropriations Bill Including Ag/FDA Funds Read More
Analysis and Commentary STEVEN GROSSMAN 9/8/17 Analysis and Commentary STEVEN GROSSMAN 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More
Advocacy at a Glance STEVEN GROSSMAN 9/8/17 Advocacy at a Glance STEVEN GROSSMAN 9/8/17 Senate Passes FY 18 CR Through December 8 and more Read More
Advocacy at a Glance STEVEN GROSSMAN 9/1/17 Advocacy at a Glance STEVEN GROSSMAN 9/1/17 A "Breather", a Summary Review, and a Re-commitment Read More
Advocacy at a Glance STEVEN GROSSMAN 9/1/17 Advocacy at a Glance STEVEN GROSSMAN 9/1/17 A Busy and Consequential Month for Congress and more Read More
